Status:
UNKNOWN
Celiac Disease Prevention
Lead Sponsor:
Kuopio University Hospital
Collaborating Sponsors:
University of Eastern Finland
University of Turku
Conditions:
Celiac Disease
Eligibility:
All Genders
Up to 2 years
Phase:
NA
Brief Summary
Celiac disease is an autoimmune disease induced by wheat gluten. Destruction of epithelial cells and microvilli on gut mucosa is causing a "flat mucosa" and an absorption defect. The diagnosis is base...
Eligibility Criteria
Inclusion
- Presence of HLA-risk alleles DQA1\*05 and DQB1\*02
Exclusion
- Lack of these HLA risk alleles
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT00617838
Start Date
October 1 2007
End Date
December 1 2014
Last Update
August 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kuopio University Hospital
Kuopio, Finland, FIN-70211